HAMP and chronic kidney disease: In the course of CKD, patients develop an inflammatory block of iron metabolism—deregulation of the hepcidin–ferroportin axis—which is manifested by characteristic laboratory changes (low iron transferrin saturation, high ferritin concentration) and resistance to iron supplementation.